Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate Psoriasis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Ended earlyNCT02829424
What this trial is testing

Multicenter Randomized Double Blind Controlled-study to Assess the Potential of Methotrexate Versus Placebo to Improve and Maintain Response to Anti TNF- Alpha Agents in Adult Patients With Moderate to Severe Psoriasis

Who this might be right for
Psoriasis
Assistance Publique Hopitaux De Marseille 78
Not applicableEnrolling By InvitationNCT06999941
What this trial is testing

A Real-world Study of Deucravacitinib in the Treatment of Moderate to Severe Plaque Psoriasis With Eczematous Features

Who this might be right for
PsoriasisEczemaJAK Inhibitor
Xi Tan 50
Not applicableStudy completedNCT01812954
What this trial is testing

Economic Evaluation of Systemic Treatments for Moderate-to-severe Psoriasis

Who this might be right for
Psoriasis
Jochen Schmitt. 1
Testing effectiveness (Phase 2)Study completedNCT02203851
What this trial is testing

Extension Trial Assessing the Safety and Efficacy of BI 655066/ABBV-066/Risankizumab in Patients With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
AbbVie 110
Testing effectiveness (Phase 2)Study completedNCT04911751
What this trial is testing

Investigate Efficacy and Safety of KBL697 in Patients with Moderate Plaque Type Psoriasis

Who this might be right for
Psoriatic Plaque
KoBioLabs 80
Testing effectiveness (Phase 2)Study completedNCT01246583
What this trial is testing

CP-690-550 Ointment For Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Pfizer 71
Large-scale testing (Phase 3)Active Not RecruitingNCT06506916
What this trial is testing

Evaluate the Effect of Bimekizumab on Gene Expression Biomarkers in Study Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Moderate to Severe Plaque PsoriasisPsoriatic Arthritis
UCB Biopharma SRL 89
Post-approval studies (Phase 4)Study completedNCT00658606
What this trial is testing

Assess the Efficacy and Safety of Alefacept With Narrow Band Ultraviolet B Phototherapy (nbUVB) vs. Alefacept Alone in Chronic Plaque Psoriasis Subjects

Who this might be right for
Plaque Psoriasis
Astellas Pharma Inc 98
Large-scale testing (Phase 3)Study completedNCT02207244
What this trial is testing

Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis With Randomized Withdrawal and Retreatment

Who this might be right for
Psoriasis
Janssen Research & Development, LLC 992
Large-scale testing (Phase 3)Study completedNCT01636687
What this trial is testing

Judging the Efficacy of Secukinumab in Patients With Psoriasis Using AutoiNjector: a Clinical Trial Evaluating Treatment Results (JUNCTURE)

Who this might be right for
Plaque-type Psoriasis
Novartis Pharmaceuticals 182
Large-scale testing (Phase 3)Study completedNCT00438399
What this trial is testing

Subject Preference for Scalp Psoriasis Treatment

Who this might be right for
Scalp Psoriasis
Galderma R&D 219
Large-scale testing (Phase 3)Study completedNCT00454584
What this trial is testing

An Efficacy and Safety Study of CNTO 1275 Compared to Etanercept in Patients With Plaque Psoriasis

Who this might be right for
Psoriasis
Centocor, Inc. 903
Large-scale testing (Phase 3)Active Not RecruitingNCT06846541
What this trial is testing

Long-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque PsoriasisPsoriasis (PsO)Psoriasis+2 more
Alumis Inc 1,680
Large-scale testing (Phase 3)Study completedNCT05174598
What this trial is testing

A Clinical Trial to Evaluate Efficacy and Safety of Two Different Formulations of Topical Calcipotriol in Patients With Mild to Moderate Plaque Psoriasis

Who this might be right for
Mild to Moderate Plaque Psoriasis
Cadila Pharnmaceuticals 278
Large-scale testing (Phase 3)Study completedNCT06488664
What this trial is testing

An Efficacy and Safety Study of GNR-068 (Ustekinumab Biosimilar) and Stelara® in the Treatment of Patients With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
AO GENERIUM 422
Large-scale testing (Phase 3)Study completedNCT01309737
What this trial is testing

A One-Year Study To Evaluate The Efficacy And Safety Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Pfizer 960
Testing effectiveness (Phase 2)Study completedNCT01071252
What this trial is testing

A Dose Ranging Study of AIN457 in Patients With Moderate to Severe Chronic Plaque-type Psoriasis

Who this might be right for
Chronic Plaque-type Psoriasis
Novartis Pharmaceuticals 125
Not applicableStudy completedNCT00894777
What this trial is testing

Study Evaluating Management of Patients With Moderate and Severe Psoriasis

Who this might be right for
Psoriasis
Wyeth is now a wholly owned subsidiary of Pfizer 469
Not applicableUnknownNCT05500794
What this trial is testing

Meditation in Inflammatory Dermatosis

Who this might be right for
Atopic DermatitisPsoriasisPruritus
Assistance Publique - Hôpitaux de Paris 72
Testing effectiveness (Phase 2)Study completedNCT00645905
What this trial is testing

Study of Two Dosing Schedules of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Abbott 148
Next Page